- Home
- ARMP vs MERC Comparison
ARMP vs MERC Comparison
Compare ARMP & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMP | MERC |
|---|---|---|
| Founded | N/A | 1968 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.7M | 106.5M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | ARMP | MERC |
|---|---|---|
| Price | $7.77 | $2.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $12.00 | $3.00 |
| AVG Volume (30 Days) | 32.6K | ★ 752.2K |
| Earning Date | 11-12-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 6.20% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,054,000.00 | ★ $1,906,971,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | N/A | $12.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.90 | $1.48 |
| 52 Week High | $16.34 | $8.28 |
Technical Indicators
Market Signals| Indicator | ARMP | MERC |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 71.59 |
| Support Level | $5.87 | $1.93 |
| Resistance Level | $6.60 | $2.07 |
| Average True Range (ATR) | 0.52 | 0.11 |
| MACD | 0.09 | 0.05 |
| Stochastic Oscillator | 89.55 | 90.53 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.